white and black paper lot

Our Research Library

Dive into over a dozen proprietary studies—mechanistic work, clinical trials, and real-world data demonstrating our formula’s effects.

5x

17.4%

5.4%

Increase in Th17 (IL-17/IL-22) CD4⁺ cells after 15 days of supplementation, with Th2 cells unchanged.

Increase in CD8⁺ cytotoxic T cells by week 8 in cancer patients, correlating with improved quality of life.

Lengthening of leukocyte telomeres after 8 weeks of supplementation in healthy Thai adults.

Highlights

Study 1 - Immune Support

Study 2 - Cancer Care Support

Study 3 - Longevity & Cellular Health

Drawing on 14 proprietary R&D studies and clinical trials, here’s what our top results show:

Study of the Operation BIM Product on the Modulation of the Immune System (Arthrinox)

All Studies & Trials

Study of the Operation BIM Product on the Modulation of the Immune System (Diabenox)

Lab Data of BIM Capsule and BIM Mangosteen Juice

Xanthones, Natural substances found in the Genus Garcinia, particularly in mangosteen

ByeByeHIV with Thai Innovation

Balancing Immunity with a Dietary Supplement Derived from Five Edible Plants for Management of Rheumatoid Arthritis

การทดสอบเชื้อ HIV ด้วยวิธี HIV-1 Provirus

Balancing Immunity with a Dietary Supplement Derived from Five Edible Plants for Management of Rheumatoid Arthritis

Study of the Operation BIM Mangosteen Juice on the Modulation of the Immune System

Comparison of the Effects of Five Thai Edible Plant Extracts on Canine Mammary Gland Carcinoma Cell Line and Canine Adipose-Derived Mesenchymal Stem Cells

Reduction of Proviral Load of Feline Leukemia Virus Employing the Immunomodulatory Property of Five Thai Edible Plant Extracts

Conducted by Asian Phytoceuticals Public Co. Ltd. (APCO Thailand, MAI-listed) as part of their Operation BIM research program, these 14 proprietary R&D studies and clinical trials dive into every aspect of Th17 & SIB—from targeted immune activation to quality-of-life outcomes and cellular health.